Christopher Reading Biovie Inc. (BIVI) insider trading activity
Christopher Reading is EVP Neuroscience R&D of BIOVIE INC.. Currently has a direct ownership of 37,148 shares of BIVI, which is worth approximately $70,581. The most recent transaction as insider was on Feb 16, 2023, when has been sold 2,476 shares (Common Stock) at a price of $6.12 per share, resulting in proceeds of $15,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
37.1K
0%
3M change
0%
12M change
Total Value Held
$70,581
CHRISTOPHER READING Transaction History
CR
Christopher Reading
EVP Neuroscience R&D
Santa Monica, CA